ACON Latest Headlines

Aclarion Targets Payer Expansion and CLARITY Trial Milestones as CEO Outlines Strategic 2026 Vision

Market Chameleon (Fri, 20-Mar 10:58 AM)

Aclarion’s Nociscan Adoption Surges: 114% Q4 Growth and Strong Cash Position Signal Momentum in AI Diagnostics

Market Chameleon (Thu, 8-Jan 9:53 AM)

Aclarion Achieves 114% Surge in Q4 Nociscan Volumes and Extends Cash Runway Into 2027

Market Chameleon (Thu, 8-Jan 7:05 AM)